PDS Biotechnology
(NASDAQ) PDSB
PDS Biotechnology Financials at a Glance
Market Cap
$34.75M
Revenue (TTM)
$0.00
Net Income (TTM)
$36.84M
EPS (TTM)
$-0.75
P/E Ratio
-0.85
Dividend
$0.00
Beta (Volatility)
1.97 (High)
Dividend
$0.00
Beta (Volatility)
1.97 (High)
Price
$0.62
Volume
234,111.253
Open
$0.59
Price
$0.62
Volume
234,111.253
Open
$0.59
Previous Close
$0.64
Daily Range
$0.58 - $0.64
52-Week Range
$0.51 - $1.92
Dividend
$0.00
Beta (Volatility)
1.97 (High)
Price
$0.62
Volume
234,111.253
Open
$0.59
Previous Close
$0.64
Daily Range
$0.58 - $0.64
52-Week Range
$0.51 - $1.92
PDSB News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout PDS Biotechnology
Industry
Biotechnology
Sector
Health CareEmployees
21
CEO
Frank K. Bedu-Addo, PhD
Website
www.pdsbiotech.comHeadquarters
Princeton, NJ 07932, US
PDSB Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-244%
Return on Capital
386%
Return on Assets
-1%
Earnings Yield
-1.18%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$34.75M
Shares Outstanding
54.72M
Volume
234.11K
Short Interest
0.00%
Avg. Volume
597.88K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$31.54B
EBITDA
$30.30M
Operating Cash Flow
$27.75B
Capital Expenditure
$0.00
Free Cash Flow
$27.75B
Cash & ST Invst.
$26.71M
Total Debt
$5.19B
PDS Biotechnology Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
+100.0%
Gross Margin
0.00%
N/A
Market Cap
$34.75M
N/A
Market Cap/Employee
$1.45M
N/A
Employees
24
N/A
Net Income
$9.90M
-24.5%
EBITDA
$6.44M
+5.8%
Quarterly Fundamentals
Net Cash
$5.17B
-26107.2%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$11.76M
+26.9%
Short Term Debt
$5.17B
+41031.2%
Return on Assets
-1.21%
N/A
Return on Invested Capital
385.54%
N/A
Free Cash Flow
$23.44B
+284708.2%
Operating Cash Flow
$23.44B
+284708.2%